Friday 12th July
08:30		Badge Collection and Welcome Coffee
09:30		Introduction Professor Derek Yellon University College London, UK
09:45		Surprising findings from clinical trials – cardiology, diabetes & nephrology Professor Marc Pfeffer Harvard University, Boston, USA
10:25		Sudden cardiac death at the limits Professor Perry Elliot University College London, UK
11:05		Break
11:35		Industry satellite symposium
12:50		Trials and Tribulations in AKI. Do we know where we are going? Professor Steven Weisbord VA Pittsburgh Healthcare System, USA
13:30		Lunch
14:30		Modern drug therapy for type 2 diabetes – the role and importance of SGLT2 inhibitors Professor Mansoor Husain University of Toronto, Canada
15:10		Primordial cardiology in youth – what are the limits? Professor John Deanfield University College London, UK
15:50		Haplotypes and pathophysiological clusters of diabetes in Latin America: are we part of the same world tribe? Professor Carlos Aguilar-Salinas Instituto Nacional de Ciencias Médicas y Nutrición, México City, México
16:30		Close
Saturday 13th July
08:00		Welcome Coffee
08:30		Heart failure therapy – extending the limits! Professor John McMurray University of Glasgow, Scotland
09:10		Cardiac atheroma at the limits – are we fighting the final battle? Professor Peter Libby The Brigham & Women’s Hospital, Harvard Medical School, Boston, USA
09:50		Break
10:20		Targets for primary hypertension with and without comorbidities Professor Brian Rayner University of Cape Town, SA
11:00		Industry satellite symposium
12:15		Lunch
13:15		Have we reached the limits of lipid lowering and outcome? Professor Rodrigo Alonso Clínica Las Condes, Santiago de Chile
13:55		HDL – its role in myocardial infarction - where do we stand? Professor Andrei Sposito University of Campinas, Brazil
14:35		Break
15:05		The central control of obesity Professor Licio Velloso University of Campinas, Brazil
15:45		Cross talk between bone, kidney and vasculature Professor John Cunningham University College London, UK
16:25		Chairs closing remarks
16:45		Close

Endorsed by:

Cardiology, Diabetes & Nephrology at the Limits Brazil is supported by educational grants from the Pharmaceutical Industry.

A list of 2019 supporters is HERE